HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Van Cutsem, Eric, Bang, Yung-Jue, Feng-yi, Feng, Xu, Jian M., Lee, Keun-Wook, Jiao, Shun-Chang, Chong, Jorge León, López-Sanchez, Roberto I., Price, Timothy, Gladkov, Oleg, Stoss, Oliver, Hill, Julie, Ng, Vivian, Lehle, Michaela, Thomas, Marlene, Kiermaier, Astrid, Rüschoff, Josef
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2015)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2015)
Get full text
Journal Article
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Bang, Yung-Jue, Prof, Van Cutsem, Eric, Prof, Feyereislova, Andrea, MD, Chung, Hyun C, Prof, Shen, Lin, Prof, Sawaki, Akira, MD, Lordick, Florian, MD, Ohtsu, Atsushi, MD, Omuro, Yasushi, MD, Satoh, Taroh, MD, Aprile, Giuseppe, MD, Kulikov, Evgeny, MD, Hill, Julie, PhD, Lehle, Michaela, PhD, Rüschoff, Josef, Prof, Kang, Yoon-Koo, Prof
Published in The Lancet (British edition) (28.08.2010)
Published in The Lancet (British edition) (28.08.2010)
Get full text
Journal Article
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
KAUFMAN, Bella, MACKEY, John R, REVIL, Cédric, JONES, Alison, CLEMENS, Michael R, BAPSY, Poonamalle P, VAID, Ashok, WARDLEY, Andrew, TJULANDIN, Sergei, JAHN, Michaela, LEHLE, Michaela, FEYEREISLOVA, Andrea
Published in Journal of clinical oncology (20.11.2009)
Published in Journal of clinical oncology (20.11.2009)
Get full text
Journal Article
First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial
UNTCH, Michael, MUSCHOLL, Michael, HARBECK, Nadia, JACKISCH, Christian, MÜLLER, Volkmar, PAUSCHINGER, Matthias, THOMSSEN, Christoph, LEHLE, Michaela, CATALANI, Olivier, LÜCK, Hans-Joachim, TJULANDIN, Sergei, JONAT, Walter, MEERPOHL, Hans-Gerd, LICHINITSER, Mikhail, MANIKHAS, Alexey G, COUMBOS, Alexandra, KREIENBERG, Rolf, DU BOIS, Andreas
Published in Journal of clinical oncology (20.03.2010)
Published in Journal of clinical oncology (20.03.2010)
Get full text
Journal Article
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3
Callaghan, Michael U., Asikanius, Elina, Lehle, Michaela, Oldenburg, Johannes, Mahlangu, Johnny, Uguen, Marianne, Chebon, Sammy, Kruse‐Jarres, Rebecca, Jiménez‐Yuste, Víctor, Shima, Midori, Trask, Peter, Kempton, Christine L., Kessler, Craig M., Levy, Gallia G., Peyvandi, Flora
Published in Research and practice in thrombosis and haemostasis (01.08.2022)
Published in Research and practice in thrombosis and haemostasis (01.08.2022)
Get full text
Journal Article
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies
Callaghan, Michael U., Negrier, Claude, Paz-Priel, Ido, Chang, Tiffany, Chebon, Sammy, Lehle, Michaela, Mahlangu, Johnny, Young, Guy, Kruse-Jarres, Rebecca, Mancuso, Maria Elisa, Niggli, Markus, Howard, Monet, Bienz, Nives Selak, Shima, Midori, Jiménez-Yuste, Victor, Schmitt, Christophe, Asikanius, Elina, Levy, Gallia G., Pipe, Steven W., Oldenburg, Johannes
Published in Blood (22.04.2021)
Published in Blood (22.04.2021)
Get full text
Journal Article
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Pipe, Steven W, Shima, Midori, Lehle, Michaela, Shapiro, Amy, Chebon, Sammy, Fukutake, Katsuyuki, Key, Nigel S, Portron, Agnès, Schmitt, Christophe, Podolak-Dawidziak, Maria, Selak Bienz, Nives, Hermans, Cedric, Campinha-Bacote, Avrita, Kiialainen, Anna, Peerlinck, Kathelijne, Levy, Gallia G, Jiménez-Yuste, Victor
Published in The Lancet. Haematology (01.06.2019)
Published in The Lancet. Haematology (01.06.2019)
Get more information
Journal Article
Pharmacodynamic Biomarkers in Infants with Hemophilia A Receiving Emicizumab in HAVEN 7
Kiialainen, Anna, Pipe, Steven, Fijnvandraat, Karin, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Oldenburg, Johannes, Mancuso, Maria Elisa, Dhalluin, Christophe, Lehle, Michaela, Collins, Peter
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial
Pipe, Steven W., Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kavakli, Kaan, Kiialainen, Anna, Deb, Sonia, Niggli, Markus, Chang, Tiffany, Lehle, Michaela, Fijnvandraat, Karin
Published in Blood (04.04.2024)
Published in Blood (04.04.2024)
Get full text
Journal Article
Population pharmacokinetics and exposure–response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer
Cosson, Valérie F., Ng, Vivian W., Lehle, Michaela, Lum, Bert L.
Published in Cancer chemotherapy and pharmacology (01.04.2014)
Published in Cancer chemotherapy and pharmacology (01.04.2014)
Get full text
Journal Article
Emicizumab Prophylaxis in Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 7 Study
Pipe, Steven, Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kavakli, Kaan, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Niggli, Markus, Fijnvandraat, Karin
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study
Pipe, Steven W., Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Fijnvandraat, Karin
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Determining meaningful health‐related quality‐of‐life improvement in persons with haemophilia A using the Haemophilia Quality of Life Questionnaire for Adults (Haem‐A‐QoL)
Mackensen, Sylvia, Catalani, Olivier, Asikanius, Elina, Paz‐Priel, Ido, Lehle, Michaela, Trask, Peter
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2020)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2020)
Get full text
Journal Article
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study
Négrier, Claude, Mahlangu, Johnny, Lehle, Michaela, Chowdary, Pratima, Catalani, Olivier, Jiménez-Yuste, Víctor, Beckermann, Benjamin M., Schmitt, Christophe, Hermans, Cedric, Ventriglia, Giuliana, Windyga, Jerzy, Kiialainen, Anna, d'Oiron, Roseline, Moorehead, Paul, Teodoro, Vanda, Shapiro, Amy D., Oldenburg, Johannes
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study
Oldenburg, Johannes, Tran, Huyen, Peyvandi, Flora, Núñez, Ramiro, Trask, Peter, Chebon, Sammy, Mahlangu, Johnny N., Lehle, Michaela, Jiménez‐Yuste, Victor, Mackensen, Sylvia
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2021)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2021)
Get full text
Journal Article
Emicizumab dose up‐titration in case of suboptimal bleeding control in people with haemophilia A
Schmitt, Christophe, Mancuso, Maria Elisa, Chang, Tiffany, Podolak‐Dawidziak, Maria, Petry, Claire, Sidonio Jr, Robert, Yoneyama, Koichiro, Key, Nigel S., Niggli, Markus, Lehle, Michaela, Peyvandi, Flora, Oldenburg, Johannes
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.01.2023)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.01.2023)
Get full text
Journal Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies
Skinner, Mark W., Négrier, Claude, Paz‐Priel, Ido, Chebon, Sammy, Jiménez‐Yuste, Victor, Callaghan, Michael U., Lehle, Michaela, Niggli, Markus, Mahlangu, Johnny, Shapiro, Amy, Shima, Midori, Campinha‐Bacote, Avrita, Levy, Gallia G., Oldenburg, Johannes, Mackensen, Sylvia, Pipe, Steven W.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2021)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2021)
Get full text
Journal Article
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS)
Mahlangu, Johnny, Oldenburg, Johannes, Callaghan, Michael U., Shima, Midori, Mancuso, Maria Elisa, Trask, Peter, Recht, Michael, Garcia, Claudia, Yang, Renchi, Lehle, Michaela, Macharia, Harrison, Asikanius, Elina, Levy, Gallia G., Kruse‐Jarres, Rebecca, von Mackensen, Sylvia
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2019)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2019)
Get full text
Journal Article
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
Négrier, Claude, Mahlangu, Johnny, Lehle, Michaela, Chowdary, Pratima, Catalani, Olivier, Bernardi, Ronald J, Jiménez-Yuste, Víctor, Beckermann, Benjamin M, Schmitt, Christophe, Ventriglia, Giuliana, Windyga, Jerzy, d'Oiron, Roseline, Moorehead, Paul, Koparkar, Sunita, Teodoro, Vanda, Shapiro, Amy D, Oldenburg, Johannes, Hermans, Cedric
Published in The Lancet. Haematology (01.03.2023)
Published in The Lancet. Haematology (01.03.2023)
Get more information
Journal Article
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non‐interventional study in a real‐world setting
Kruse‐Jarres, Rebecca, Oldenburg, Johannes, Santagostino, Elena, Shima, Midori, Kempton, Christine L., Kessler, Craig M., Lehle, Michaela, Chebon, Sammy, Selak Bienz, Nives, Asikanius, Elina, Mahlangu, Johnny
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2019)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2019)
Get full text
Journal Article